Latest Interviews
Showing 1816–1830 of 3,136 interview transcripts.
Clear all filters- The Diary Of A CEO1h 31m
Michael Buble: "I Will NEVER Be Carefree Again!", Rejection, Cancer & Stealing!
Michael Bublé recounts a career defined by a decade of rejection and the strategic independence required to self-fund a demo that secured his Warner Bros. deal, ultimately achieving global success through his pivot to Southeast Asia. His trajectory shifted profoundly following his son Noah's cancer diagnosis, a crisis that dismantled his professional ego and reoriented his priorities toward faith, family, and a deliberate separation between his polished stage persona and his authentic personal identity. Currently, Bublé is leveraging his platform to explore acting, launch his Fraser & Thompson whiskey brand, and disrupt industry gatekeepers via social media, while maintaining a grounded perspective on wealth and legacy.
- Goldman Sachs33 min
Asset allocation outlook: The case for greater portfolio diversification in 2024
Christian Mueller-Glissmann, Alexandra Wilson-Elizondo, Alison Nathan
Goldman Sachs Research and Asset Management teams project a 2024 landscape defined by a strategic rotation out of underweight cash holdings toward a rebalanced 60-40 equity-bond mix to capitalize on normalizing inflation and renewed diversification benefits. While the U.S. economy is identified as late-cycle with a 30% recession probability, the firms recommend extending fixed income duration, utilizing equity put options for downside protection, and increasing exposure to private markets and real assets to navigate persistent structural inflation and AI-driven productivity divergence. This comprehensive strategy aims to achieve a soft landing by hedging against rising credit delinquencies and supply pressures while actively capturing alpha in a higher-rate environment where zero-interest rates are not expected to return.
- a16z1h 27m
Tony Robbins on the Future of Health & Longevity
Tony Robbins, Ben Horowitz, Marc Andreessen, Dr. Vijay Pande
Mark Cuban, Ben Horowitz, and Tony Robbins convened to examine the lag between medical innovation and clinical adoption, using Robbins' successful recovery from a severe neck and shoulder injury via unapproved stem cell therapy as a primary case study. The discussion highlighted how regulatory barriers, insurance dynamics, and academic stagnation currently hinder breakthrough treatments in fields ranging from precision medicine to mental health, while also addressing the societal need to shift from victimhood narratives toward personal autonomy. To bridge these gaps, the speakers outlined a vision where patients act as CEOs of their own health through data-driven diagnostics and retraining for a purpose-driven workforce, ultimately calling for a system that rewards outcomes over volume.
- Goldman Sachs28 min
Focus on financials: Why banks and asset managers are constructive about the economy in 2024
Richard Ramsden, Alex Blostein, Alison Nathan
Financial institutions now anticipate a soft landing with reduced recession risks, driven by stable deposit flows and a shift toward a higher-for-longer interest rate environment. While commercial lending stagnates due to tightened underwriting and regulatory capital requirements, the private credit sector is expanding rapidly as non-bank lenders absorb displaced loan demand. Concurrently, banks are fortifying reserves against commercial office real estate exposure and navigating a contentious regulatory framework that could further compress traditional intermediation while accelerating industry consolidation.
- The Diary Of A CEO1h 25m
The No.1 Menopause Doctor: They’re Lying To You About Menopause! Mary Claire Haver
Mary Claire Haver, Dr Mindy Pelz, Dr Mary
OB-GYN Dr. Mary Claire Haver addresses the critical gap in menopause education by exposing systemic failures that leave 89.5% of symptomatic women without treatment despite the condition affecting 1.2 billion people globally. She challenges historical misconceptions from the flawed Women's Health Initiative while advocating for evidence-based interventions like transdermal hormone replacement therapy, the Galveston Diet, and strength training to mitigate cardiovascular, metabolic, and cognitive risks. With an upcoming book titled *The New Menopause* and a focus on medical reform, Haver urges women to overcome stigma through self-advocacy to improve longevity and quality of life during perimenopause and postmenopause.
- a16z15 min
2024 Big Ideas: Anime Games Go Mainstream with Robin Guo
General Partner a16z's 2024 "Big Ideas" report identifies the expanding anime gaming ecosystem as a primary investment opportunity, citing *Genshin Impact* and *Honkai Impact 3rd* as benchmarks for cross-platform performance and revenue models exceeding industry averages. The analysis details how "gacha" monetization, evolving AI asset tools, and a shift from niche to mainstream demographics have lowered barriers for new entrants while driving billions in revenue. With studios like HoYoverse setting new standards for narrative depth and gameplay integration, the sector is poised for further growth in immersive XR experiences and AI-driven endless games.
- a16z24 min
2024 Big Ideas: AI-First Games That Never End with Jonathan Lai
A16Z partner Jonathan Lai forecasts a 2024 shift toward "AI-native" games that utilize Large Language Models to create dynamic, non-repeating narratives and lifelike companions rather than merely accelerating development. While current studios leverage AI for efficiency, new entrants are poised to disrupt the $200 billion market by pioneering subscription-based models designed to manage the variable costs of real-time generative processing. This evolution promises to reinvent core mechanics across genres, transforming static experiences into emergent worlds where players interact with adaptive agents.
- Goldman Sachs26 min
Middle East risks
Edward P. Djerejian, Emile Hokayem, Alison Nathan
Former U.S. Ambassador Edward Jerijian and IIS Senior Fellow Emile Hokeyem analyze how the October 7th attacks successfully recentered the Palestinian cause while triggering a broader regional conflict involving Iran-aligned groups in Iraq, Syria, and Yemen. Experts warn that although Hamas has achieved its goal of ending the marginalization of Palestine, Israel remains committed to its military destruction while facing significant risks of miscalculation due to Hezbollah's involvement and disruptions to global oil flows. The prevailing consensus identifies a two-state solution as the only viable long-term resolution, yet current Israeli political constraints and the absence of credible Palestinian leadership render such a framework impossible in the immediate future.
- a16z15 min
Redefining Partnership with Adam Neumann
Adam Neumann, Ben Horowitz, Mark Andreessen, Elon Stern, Scott Writer, Caroline
Flow Living, founded by Adam and supported by a fully aligned financial partnership including a $350 million personal investment from Adam and Andreessen Horowitz, addresses the US housing supply gap by operating as a vertically integrated property manager, technology provider, and landlord. The company recently appointed CTO Scott Writer to lead technical strategy, leveraging his expertise in managing systems for billions of users to modernize a legacy real estate stack and implement dynamic pricing algorithms. Moving beyond traditional rent collection, Flow now controls 34% of a resident's income wallet through a unified app and is piloting an AI-driven community commerce model in Miami to drive retention and solve fragmentation in the market.
- a16z14 min
Big Ideas in 2024: Voice-First Apps Will Become Integral to Our Lives with Anish Acharya
A16Z partner Anish Acharya argues that advancements in large language models are transforming voice into a primary productivity interface by solving the historical "90% fidelity" problem that limited previous attempts. This shift enables new entrants to disrupt incumbents like Gmail through native voice-first workflows, moving human-computer interaction from simple commands to complex, passive conversations reminiscent of the film *Her*. While voice and graphical interfaces remain complementary, the technology is rapidly overcoming social and training barriers to redefine how executives and consumers manage digital tasks.
- The Economist6 min
Is nuclear fusion the future of clean energy?
Following record-breaking plasma temperatures at 100 million degrees Celsius, private fusion startups like Tokamak Energy and US-based Commonwealth Fusion Systems are racing to achieve commercial net energy production by the 2030s. This ambitious timeline relies on overcoming significant engineering hurdles in materials science and containment through a collaboration between global firms and public research bodies such as the UK's Atomic Energy Authority. With over $6 billion in investment fueling more than 42 private entities, the industry aims to deliver stable, low-waste baseload power as a critical solution for global decarbonization.
- The Diary Of A CEO1h 38m
“Dynamo Is Dead!” The Heartbreaking True Story Of Why Dynamo Vanished For Years!
After disappearing from the public eye between 2017 and 2020 due to severe Crohn's disease, a failed drug deal with his abusive father, and a suicide attempt in 2020, magician Steven Fraser publicly addresses his trauma to dismantle his "Dynamo" persona. He is launching the Sky TV series *Dynamo Is Dead*, which features a live performance symbolizing the death of his former identity, alongside new nutritional partnerships and a return to magic focused on working-class mental health advocacy. This transition marks his shift from an impossible performer to a therapist-supported individual using his platform to normalize seeking help for physical and psychological suffering.
- a16z35 min
Launching a New Category with Modern Treasury's Dimitri Dadiomov
Dimitri Dadiomov, Seema Amble, Dmitry Dadimov
Launched in 2018 by Dmitry Dadimov, Sam Aaron, and Matt Marcus, Modern Treasury addresses complex payment reconciliation challenges by providing a unified platform that bridges developer APIs with financial dashboards. The company initially targeted early-stage startups with a "three-legged stool" architecture combining bank integrations and manual oversight tools before securing its first client through personal networks. By coining the "Payment Operations" category and prioritizing deep product mastery over competitive tracking, the founders established a defensible market position that evolved from manual reconciliation into a standardized infrastructure solution.
- Goldman Sachs20 min
M&A in 2024: Navigating opportunities and challenges
Stephan Feldgoise, Mark Sorrell, Allison Nathan
Following a 2023 period defined by valuation misalignments and high interest rates, the M&A market is experiencing a surge in dialogue and specific sector activity driven by resilient natural resources, healthcare, and stable industrial performance. While private equity deal volume has contracted due to financing costs, corporate buyers have maintained robust activity and public-to-private transactions have reached record levels to address pressure on portfolio monetization. Looking ahead to 2024, experts anticipate a normalization of interest rates and reduced inflation will catalyze a rebound in technology deals and strategic spinoffs, with international activity expected to trail the US market by several months.
- a16z25 min
Big Ideas in 2024: Programming Medicine’s Final Frontier with Jorge Conde
Jorge Conde of a16z Bio + Health proposes "programming medicine" as a paradigm shift that reuses delivery platforms like SpaceX rockets to accelerate the development of genetic therapies beyond traditional bespoke drug cycles. This approach, validated by the recent FDA approval of a CRISPR-based sickle cell treatment achieved in just over a decade, aims to transform biological manufacturing through regulatory adaptability and engineering precision. Despite current hurdles regarding permanent safety, complex logistics, and multi-million dollar costs, the strategy seeks to apply exponential scaling to reduce treatment prices from millions to thousands of dollars for broader patient access.